Document Detail


Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
MedLine Citation:
PMID:  24687169     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IMPORTANCE: Metformin treatment is associated with improved outcome after myocardial infarction in patients with diabetes. In animal experimental studies metformin preserves left ventricular function.
OBJECTIVE: To evaluate the effect of metformin treatment on preservation of left ventricular function in patients without diabetes presenting with ST-segment elevation myocardial infarction (STEMI).
DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled study conducted among 380 patients who underwent primary percutaneous coronary intervention (PCI) for STEMI at the University Medical Center Groningen, The Netherlands, between January 1, 2011, and May 26, 2013.
INTERVENTIONS: Metformin hydrochloride (500 mg) (n = 191) or placebo (n = 189) twice daily for 4 months.
MAIN OUTCOMES AND MEASURES: The primary efficacy measure was left ventricular ejection fraction (LVEF) after 4 months, assessed by magnetic resonance imaging. A secondary efficacy measure was the N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration after 4 months. The incidence of major adverse cardiac events (MACE; the combined end point of death, reinfarction, or target-lesion revascularization) was recorded until 4 months as a secondary efficacy measure.
RESULTS: At 4 months, all patients were alive and none were lost to follow-up. LVEF was 53.1% (95% CI, 51.6%-54.6%) in the metformin group (n = 135), compared with 54.8% (95% CI, 53.5%-56.1%) (P = .10) in the placebo group (n = 136). NT-proBNP concentration was 167 ng/L in the metformin group (interquartile range [IQR], 65-393 ng/L) and 167 ng/L in the placebo group (IQR, 74-383 ng/L) (P = .66). MACE were observed in 6 patients (3.1%) in the metformin group and in 2 patients (1.1%) in the placebo group (P = .16). Creatinine concentration (79 µmol/L [IQR, 70-87 µmol/L] vs 79 µmol/L [IQR, 72-89 µmol/L], P = .61) and glycated hemoglobin (5.9% [IQR, 5.6%-6.1%] vs 5.9% [IQR, 5.7%-6.1%], P = .15) were not significantly different between both groups. No cases of lactic acidosis were observed.
CONCLUSIONS AND RELEVANCE: Among patients without diabetes presenting with STEMI and undergoing primary PCI, the use of metformin compared with placebo did not result in improved LVEF after 4 months. The present findings do not support the use of metformin in this setting.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01217307.
Authors:
Chris P H Lexis; Iwan C C van der Horst; Erik Lipsic; Wouter G Wieringa; Rudolf A de Boer; Ad F M van den Heuvel; Hindrik W van der Werf; Remco A J Schurer; Gabija Pundziute; Eng S Tan; Wybe Nieuwland; Hendrik M Willemsen; Bernard Dorhout; Barbara H W Molmans; Anouk N A van der Horst-Schrivers; Bruce H R Wolffenbuttel; Gert J ter Horst; Albert C van Rossum; Jan G P Tijssen; Hans L Hillege; Bart J G L de Smet; Pim van der Harst; Dirk J van Veldhuisen;
Related Documents :
23952289 - High reloading dose of atorvastatin prior to percutaneous coronary intervention can red...
7884359 - Use of artificial neural networks within deterministic logic for the computer ecg diagn...
23482079 - Alcohol consumption and 5-year change in left atrial volume among patients with coronar...
24557149 - Role of masked coronary heart disease in patients with recent-onset atrial fibrillation...
16865219 - Electrocardiographical case. a man found unconscious.
4013989 - Two-dimensional echocardiography versus surface electrocardiography for the diagnosis o...
7480969 - Treatment of myocardial infarction: hypotensive effect of different thrombolytic agents.
21208239 - Successful epicardial ablation of idiopathic mitral annular ventricular tachycardia fro...
21925839 - Cardioprotective effects of low-dose combination therapy with a statin and an angiotens...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JAMA     Volume:  311     ISSN:  1538-3598     ISO Abbreviation:  JAMA     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-04-16     Completed Date:  2014-04-28     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1526-35     Citation Subset:  AIM; IM    
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT01217307
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Double-Blind Method
Female
Humans
Hypoglycemic Agents / therapeutic use*
Magnetic Resonance Imaging
Male
Metformin / therapeutic use*
Middle Aged
Myocardial Infarction / complications,  drug therapy*,  physiopathology
Percutaneous Coronary Intervention
Treatment Outcome
Ventricular Dysfunction, Left / prevention & control*
Ventricular Function, Left / drug effects*
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 9100L32L2N/Metformin
Investigator
Investigator/Affiliation:
Iwan C C van der Horst / ; Chris P H Lexis / ; Erik Lipsic / ; Pim van der Harst / ; Dirk J van Veldhuisen / ; Wouter G Wieringa / ; Rudolf A de Boer / ; Ad F M van den Heuvel / ; Hindrik W van der Werf / ; Remco A J Schurer / ; Gabija Pundziute / ; Eng S Tan / ; Hendrik M Willemsen / ; Anouk N A van der Horst-Schrivers / ; Bruce H R Wolffenbuttel / ; Bernard Dorhout / ; Hans L Hillege / ; Wybe Nieuwland / ; Peter van der Meer / ; René A Tio / ; Jenifer Coster / ; Yoran M Hummel / ; Barbara H W Molmans / ; Gert J ter Horst / ; Remco Renken / ; Anita J Sibeijn-Kuiper / ; Bart J G L de Smet / ; Albert C van Rossum / ; Robin Nijveldt / ; Jan G P Tijssen / ; Iwan C C van der Horst / ; Erik Lipsic / ; Pim van der Harst / ; Rudolf A de Boer / ; Anouk N A van der Horst-Schrivers / ; Bruce H R Wolffenbuttel / ; Dirk J van Veldhuisen / ; Chris P H Lexis / ; Iwan C C van der Horst / ; Erik Lipsic / ; Pim van der Harst / ; Dirk J van Veldhuisen / ; Jan G P Tijssen / ; Robert J de Winter / ; Arne J Risselada / ; Richard M de Jong / ; Rob K Gonera / ; Vincent M Roolvink / ; André P van Beek / ; Fred van den Berg /
Comments/Corrections
Comment In:
Nat Rev Cardiol. 2014 Jun;11(6):314   [PMID:  24736756 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Maternal bonding in mothers with postpartum anxiety disorder: the crucial role of subclinical depres...
Next Document:  A neuron-inspired computational architecture for spatiotemporal visual processing : Real-time visual...